Author: Jayakar Thomas

Publisher: Jaypee Brothers Medical Publishers

Published: 2019-02-28

Total Pages: 180

ISBN-13: 9352705939

1. Apremilast in Psoriasis-A Prospective Real-world Study 1 2. Comparative Effectiveness of Abatacept, Apremilast, Secukinumab and Ustekinumab Treatment of Psoriatic Arthritis: A Systematic Review and Network Meta-analysis 3. Management of Common Side Effects of Apremilast 4. Apremilast for the Treatment of Moderate?to?Severe Palmoplantar Psoriasis: Results from a Double?Blind, Placebo?Controlled, Randomized Study 5. Long-term Safety and Tolerability of Apremilast in Patients with Psoriasis: Pooled Safety Analysis for ?156 Weeks from 2 Phase 3, Randomized Controlled Trials (ESTEEM 1 and 2) 6. Secukinumab and Apremilast Combination Therapy for Recalcitrant Psoriasis 7. Apremilast: A Review in Psoriasis and Psoriatic Arthritis 8. Serum Squamous Cell Carcinoma Antigen in Psoriasis: A Potential Quantitative Biomarker for Disease Severity 9. Long-term Real-life Safety Profile and Effectiveness of Fumaric Acid Esters in Psoriasis Patients: A Single-Centre, Retrospective, Observational Study 10. Association between Circulating 25-hydroxyvitamin D Levels and Psoriasis, and Correlation with Disease Severity: A Meta-analysis 11. Maintenance of Skin Clearance with Ixekizumab Treatment of Psoriasis: Three-Year Results from the UNCOVER-3 Study 12. Psoriasis and the Risk of Diabetes: A Prospective Population-based Cohort Study 13. Psoriatic Patients with Chronic Viral Hepatitis do not have an Increased Risk of Liver Cirrhosis Despite Long-term Methotrexate Use: Real-world Data from a Nationwide Cohort Study in Taiwan 14. Reporting of Outcomes in Randomized Controlled Trials on Nail Psoriasis: A Systematic Review 15. Risk of Cancer in Patients with Psoriasis on Biological Therapies: A Systematic Review 16. Safety of Adalimumab Dosed Every Week and Every Other Week: Focus on Patients with Hidradenitis Suppurativa or Psoriasis 17. Secukinumab Treatment of Moderate to Severe Plaque Psoriasis in Routine Clinical Care: Real-life Data of Prior and Concomitant Use of Psoriasis Treatments from the PROSPECT Study 18. Serum Levels of Psoriasin (S100A7) and Koebnerisin (S100A15) as Potential Markers of Atherosclerosis in Patients with Psoriasis 19. Simulating the Life Course of Psoriasis Patients: The Interplay between Therapy Intervention and Marital Status 20. Smoking Paradox in the Development of Psoriatic Arthritis among Patients with Psoriasis: A Population-based Study 21. Stricturing and Fistulizing Crohn's Disease is Associated with Anti-tumor Necrosis Factor-induced Psoriasis in Patients with Inflammatory Bowel Disease 22. Studying the Effect of Systemic and Biological Drugs on Intima-Media Thickness in Patients Suffering from Moderate and Severe Psoriasis 23. Systemic Immune Mechanisms in Atopic Dermatitis and Psoriasis with Implications for Treatment 24. The Akkermansia-muciniphila is a gut Microbiota Signature in Psoriasis 25. Topical Corticosteroid Concerns among Parents of Children with Psoriasis Versus Atopic Dermatitis: A French Multicentre Cross-sectional Study 26. Fumaric Acid Esters in Combination with a 6-week Course of Narrowband Ultraviolet B Provides an Accelerated Response Compared with Fumaric Acid Esters Monotherapy in Patients with Moderate-to-Severe Plaque Psoriasis: A Randomized Prospective Clinical Study 27. Association between Obesity and Pediatric Psoriasis 28. Real-world Health Outcomes in Adults with Moderate-to-Severe Psoriasis in the United States: A Population Study Using Electronic Health Records to Examine Patient-perceived Treatment Effectiveness, Medication Use, and Healthcare Resource Utilization 29. Dietary Recommendations for Adults with Psoriasis or Psoriatic Arthritis from the Medical Board of the National Psoriasis Foundation: A Systematic Review 30. Turmeric Tonic as a Treatment in Scalp Psoriasis: A